BRUNS INGMAR (Chief Medical Officer) received a stock award from ZENTALIS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2025ACC: 0001725160-25-000037
Officer· Chief Medical Officer
Since Feb 2026
+33.26K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.26K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.63K
Price / share
—
Trade value
—
% of position
New position
2/3/2025
0.00→16.63K
Total
Net shares
+16.63K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | A · Award | +16.63K | — | — | New position | 0.00 | 16.63K |
| Total | +16.63K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
16.63K shares
Shares
+16.63K
Strike price
1.68
Held after
16.63K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16.63K shares | 2/3/2025 | A · Award | +16.63K | 1.68 | — | 16.63K |